Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Read More…
Industry, Sector and Symbol
Industry Hospitals
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone205-967-7116
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$4.28 billion
Profitability
Miscellaneous
Employees30,060
Next Earnings DateN/A
OptionableOptionable
Encompass Health (NYSE:EHC) Frequently Asked Questions
What is Encompass Health's stock symbol?
Encompass Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EHC."
How often does Encompass Health pay dividends? What is the dividend yield for Encompass Health?
Encompass Health declared a quarterly dividend on Tuesday, July 23rd. Stockholders of record on Tuesday, October 1st will be given a dividend of $0.28 per share on Tuesday, October 15th. This represents a $1.12 annualized dividend and a dividend yield of 1.67%. The ex-dividend date is Monday, September 30th. This is a boost from Encompass Health's previous quarterly dividend of $0.27. View Encompass Health's Dividend History.
How were Encompass Health's earnings last quarter?
Encompass Health Corp (NYSE:EHC) released its quarterly earnings results on Monday, July, 29th. The company reported $1.08 EPS for the quarter, beating analysts' consensus estimates of $0.97 by $0.11. The company had revenue of $1.14 billion for the quarter, compared to analyst estimates of $1.13 billion. Encompass Health had a net margin of 7.01% and a return on equity of 24.10%. View Encompass Health's Earnings History.
What price target have analysts set for EHC?
7 equities research analysts have issued 12 month price objectives for Encompass Health's shares. Their forecasts range from $70.00 to $86.00. On average, they anticipate Encompass Health's stock price to reach $74.60 in the next twelve months. This suggests a possible upside of 10.9% from the stock's current price. View Analyst Price Targets for Encompass Health.
What is the consensus analysts' recommendation for Encompass Health?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last year. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Encompass Health.
Has Encompass Health been receiving favorable news coverage?
Media stories about EHC stock have trended somewhat positive recently, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Encompass Health earned a daily sentiment score of 1.8 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near term. View News Stories for Encompass Health.
Who are some of Encompass Health's key competitors?
Some companies that are related to Encompass Health include Ramsay Health Care Limited Fully Paid Ord. Shrs (RHC), Healthscope (HSO), Select Medical (SEM), MEDNAX (MD), Primary Health Care (PRY), Magellan Health (MGLN), Medical Facilities (DR), Capitol Health (CAJ), Animalcare Group (ANCR), SunLink Health Systems (SSY), Spine Injury Solutions (SPIN) and THC Biomed Intl (THC).
What other stocks do shareholders of Encompass Health own?
Who are Encompass Health's key executives?
Encompass Health's management team includes the folowing people:
- Mr. Mark J. Tarr, CEO, Pres & Director (Age 57)
- Mr. Douglas E. Coltharp, Exec. VP & CFO (Age 57)
- Mr. John Patrick Darby, Exec. VP, Gen. Counsel & Corp. Sec. (Age 54)
- Ms. Barbara Ann Jacobsmeyer, Exec. VP & Pres Inpatient Hospitals (Age 53)
- Mr. Andrew L. Price, Sr. VP & Chief Accounting Officer (Age 52)
How do I buy shares of Encompass Health?
Shares of EHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Encompass Health's stock price today?
One share of EHC stock can currently be purchased for approximately $67.26.
How big of a company is Encompass Health?
Encompass Health has a market capitalization of $6.63 billion and generates $4.28 billion in revenue each year. The company earns $292.30 million in net income (profit) each year or $3.63 on an earnings per share basis. Encompass Health employs 30,060 workers across the globe.View Additional Information About Encompass Health.
What is Encompass Health's official website?
How can I contact Encompass Health?
Encompass Health's mailing address is 9001 LIBERTY PARKWAY, BIRMINGHAM AL, 35242. The company can be reached via phone at 205-967-7116 or via email at [email protected]
MarketBeat Community Rating for Encompass Health (NYSE EHC)
MarketBeat's community ratings are surveys of what our community members think about Encompass Health and other stocks. Vote "Outperform" if you believe EHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
